« Return to Medscape

Developed under the direction and sponsorship of Lilly USA, LLC.

INSPIRATION

Historically, CDK4 and CDK6 were believed to be functionally equivalent4,5

More recent preclinical evidence suggests that their roles can differ5-17

References: 1. Matsushime H, Ewen ME, Strom DK, et al. Cell. 1992;71:323-334. 2. Meyerson M, Harlow E. Mol Cell Biol. 1994;14:2077-2086. 3. Coller HA. Nat Rev Mol Cell Biol. 2007;8:667-670. 4. Ortega S, Malumbres M, Barbacid M. Biochimica et Biophysica Acta. 2002;1602:73-87. 5. Choi YJ, Anders L. Oncogene. 2014;33:1890-1903. 6. Reddy HKDL, Mettus RV, Rane SG, Graña X, Litvin J, Reddy EP. Cancer Res. 2005;65:10174-10178. 7. Martín J, Hunt SL, Dubus P, et al. Oncogene. 2003;22:5261-5269. 8. Jirawatnotai S, Aziyu A, Osmundson EC, et al. J Biol Chem. 2004;279:51100-51106. 9. Yu Q, Sicinska E, Geng Y, et al. Cancer Cell. 2006;9:23-32. 10. Bryja V, Pacherník J, Vondráček J, et al. Cell Prolif. 2008;41:875-893. 11. Scheicher R, Hoelbl-Kovacic A, Bellutti F, et al. Blood. 2015;125:90-101. 12. Muñoz-Alonso MJ, Acosta JC, Richard C, Delgado MD, Sedivy J, León J. J Biol Chem. 2005;280:18120-18129. 13. Jia Y, Domenico J, Swasey C, Wang M, Gelfand EW, Lucas JJ. PLoS ONE. 2014;9:e97448. 14. Hu MG, Deshpande A, Enos M, et al. Cancer Res. 2009;69:810-818. 15. Malumbres M, Barbacid M. Nat Rev Cancer. 2009;9:153-166. 16. Matushansky I, Radparvar F, Skoultchi AI. Oncogene. 2003;22:4143-4149. 17. Lucas JJ, Domenico J, Gelfand EW. Mol Cancer Res. 2004;2:105-114.

©Lilly USA, LLC 2017. All rights reserved. This site is intended for US healthcare professionals only.
PP-ON-US-1566 02/2017